Characterization of the feline thyroglobulin promoter

Cotter SM. Uncommon disorders in the cat. Proceedings of the American Animal Hospital Association’s 46th Annual Meeting 1979;115–17. Peterson ME, Johnson GF, Andrews LK. Spontaneous hyperthyroidism in the cat. Proceedings of the American College of Veterinary Internal Medicine 1979;108. Peterson, 1983, Feline hyperthyroidism, J Am Vet Med Assoc, 183, 103 Scarlett, 1988, Feline hyperthyroidism, Preventative Veterinary Medicine, 6, 295, 10.1016/0167-5877(88)90041-4 Thoday, 1992, Historical, clinical and laboratory features of 126 hyperthyroid cats, Vet Rec, 131, 257, 10.1136/vr.131.12.257 Leav, 1976, Adenomas and carcinomas of the canine and feline thyroid, Am J Pathol, 83, 61 Holzworth, 1980, Hyperthyroidism in the cat, J Am Vet Med Assoc, 176, 345 Hoenig, 1982, Toxic nodular goitre in the cat, J Small Anim Pract, 23, 1, 10.1111/j.1748-5827.1982.tb01629.x Peterson ME, Ferguson DC. Thyroid diseases. In: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, Ettinger SJ (ed) 3rd ed. W.B. Saunders, Philadelphia: 1989. p. 1632–75. Hart, 1995, Targeted gene therapy, Br Med Bull, 51, 647, 10.1093/oxfordjournals.bmb.a072984 Vile, 1993, Use of tissue-specific expression of the herpes simplex thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA, Cancer Res, 53, 3860 Siders, 1996, Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells, Cancer Res, 56, 5638 Dematteo, 1997, Engineering tissue-specific expression of a recombinant adenovirus, J Surg Res, 72, 155, 10.1006/jsre.1997.5096 Clark, 1997, Selective cell ablation in transgenic mice expression E, coli nitroreductase. Gene Ther, 4, 101, 10.1038/sj.gt.3300367 Anderson, 1999, Adenovirus-mediated tissue targeted expression of HSVtk for the treatment of breast cancer, Gene Ther, 6, 854, 10.1038/sj.gt.3300909 Osaki, 1994, Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene, Cancer Res, 54, 5258 Crystal, 1997, Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine, Hum Gene Ther, 8, 985, 10.1089/hum.1997.8.8-985 Brand, 1998, Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach, Gene Ther, 5, 1363, 10.1038/sj.gt.3300728 Manome, 1994, Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir, Cancer Res, 54, 5408 Ring, 1997, Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme, Gene Ther, 4, 1045, 10.1038/sj.gt.3300510 Pang, 1995, Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer, Hum Gene Ther, 6, 1417, 10.1089/hum.1995.6.11-1417 Gotoh, 1998, Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer, J Urol, 160, 220, 10.1016/S0022-5347(01)63094-5 Christophe, 1985, An unusually long poly(purine)-poly(pyrimidine) sequence is located upstream from the human thyroglobulin gene, Nucleic Acids Res, 13, 5127, 10.1093/nar/13.14.5127 Donda, 1991, Isolation and characterization of the canine thyroglobulin gene promoter region, Biochim Biophys Acta, 1090, 235, 10.1016/0167-4781(91)90107-W de Martynoff, 1987, Structural organization of the bovine thyroglobulin gene and of its 5′-flanking region, Eur J Biochem, 164, 591, 10.1111/j.1432-1033.1987.tb11168.x Musti, 1987, A cell type specific factor recognizes the rat thyroglobulin promoter, Nucleic Acids Res, 15, 8149, 10.1093/nar/15.20.8149 Bishop JO, al-Shawi R, Wallace H. Method of altering the metabolic state of non-dividing cells and obtained transgenic animals. Patent, University of Edinburgh, EP 049776-A 1, 1992. Ledent, 1990, Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice, Proc Natl Acad Sci USA, 87, 6176, 10.1073/pnas.87.16.6176 Ledent, 1991, Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice, Endocrinology, 129, 1391, 10.1210/endo-129-3-1391 Ledent, 1992, Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism, EMBO J, 11, 537, 10.1002/j.1460-2075.1992.tb05084.x Ledent, 1995, Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene, Oncogene, 10, 1789 Rochefort, 1996, Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter, Oncogene, 12, 111 Feunteun, 1997, Targeted oncogenesis in the thyroid of transgenic mice, Horm Res, 47, 137, 10.1159/000185456 Siebert, 1995, An improved PCR method for walking in uncloned genomic DNA, Nucleic Acids Res, 23, 1087, 10.1093/nar/23.6.1087 Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Laboratory Press, Cold Spring Harbor, 1982. Boshart, 1992, Reporter gene constructs with low background utilising the CAT gene, Gene, 110, 129, 10.1016/0378-1119(92)90456-Y Luckow, 1987, CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements, Nucleic Acids Res, 15, 5490, 10.1093/nar/15.13.5490 Christophe, 1989, Identification of a cAMP-responsive region in thyroglobulin gene promoter, Mol Cell Endocrinol, 64, 5, 10.1016/0303-7207(89)90060-9 Donda, 1993, Human, bovine, canine and rat thyroglobulin promoter sequences display species-specific differences in an in vitro study, Mol Cell Endocrinol, 90, R23, 10.1016/0303-7207(93)90162-D Ambesi-Impiombato, 1980, Culture of hormone-dependent functional epithelial cells from rat thyroids, Proc Natl Acad Sci USA, 77, 3455, 10.1073/pnas.77.6.3455 Gerber H, Peter H, Bosiger J, Studer H, Drews R, Ferguson DC, Peterson ME, Becker DV. Different continuous cell lines from adenomatous feline goiters widely differ in morphologic, functional and growth parameters. In: Progress in Thyroid Research Gordon A, Gross J, Hennemann G (eds). Rotterdam and Brookfield, Balkema, 1991. p. 541–4. Crandell, 1973, Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK), In Vitro, 9, 176, 10.1007/BF02618435 Jarrett, 1973, Determinants of host range of feline leukaemia viruses, J Gen Virol, 20, 169, 10.1099/0022-1317-20-2-169 Flynn, 1994, Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier free synthetic peptide, J Virol, 68, 5835, 10.1128/JVI.68.9.5835-5844.1994 Bradford, 1976, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Lee, 1989, Induction of nuclear protein factors specific for hormone-responsive region during activation of thyroglobulin gene by thyrotropin in rat thyroid FRTL-5 cells, J Biol Chem, 264, 7523, 10.1016/S0021-9258(18)83266-5 Zannini, 1992, Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters, Mol Cell Biol, 12, 4230, 10.1128/MCB.12.9.4230 Sinclair, 1990, The tissue-specific expression of the thyroglobulin gene requires interaction between thyroid-specific and ubiquitous factors, Eur J Biochem, 193, 311, 10.1111/j.1432-1033.1990.tb19339.x Civitareale, 1994, Purification and characterization of thyroid transcription factor 2, Biochem J, 304, 981, 10.1042/bj3040981 Fabbro, 1994, Expression of thyroid specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasia, Cancer Res, 54, 4744 Van Renterghem, 1996, Pax 8 expression in primary cultured dog thyrocyte is increased by cyclic AMP, Biochim Biophys Acta, 1307, 97, 10.1016/0167-4781(96)00018-8 Kambe, 1996, Mediation of the hormone- and serum-dependent regulation of thyroglobulin gene expression by thyroid transcription factors in rat thyroid FRTL-5 cells, J Endocrinol, 150, 287, 10.1677/joe.0.1500287 Fabbro, 1998, Pax-8 protein levels regulate thyroglobulin gene expression, J Mol Endocrinol, 21, 347, 10.1677/jme.0.0210347 Francis-Lang, 1992, Multiple mechanisms of interference between transformation and differentiation in thyroid cells, Mol Cell Biol, 12, 5793, 10.1128/MCB.12.12.5793 Javaux, 1992, Functional role of TTF-1 binding sites in bovine thyroglobulin promoter, FEBS Lett, 300, 222, 10.1016/0014-5793(92)80850-G Civitareale, 1989, A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter, EMBO J, 8, 2537, 10.1002/j.1460-2075.1989.tb08391.x Scheidereit, 1983, The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus, Nature, 304, 749, 10.1038/304749a0 Zajac, 1995, Transcriptional control and the regulation of endocrine genes, Clin Exp Pharmacol Physiol, 22, 935, 10.1111/j.1440-1681.1995.tb02330.x Wang, 1998, A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity, Endocrinology, 139, 1054, 10.1210/en.139.3.1054 Schule, 1988, Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor, Nature, 332, 87, 10.1038/332087a0 Muller, 1991, Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s), Mol Endocrinol, 5, 1498, 10.1210/mend-5-10-1498 Rothmann, 1996, Heart muscle-specific gene expression using replication defective recombinant adenovirus, Gene Ther, 3, 919 Guo, 1996, Evaluation of promoter strength for hepatic gene expression following adenovirus-mediated gene transfer, Gene Ther, 3, 802 Franz, 1997, Analysis of tissue-specific gene delivery by recombinant adenovirus containing cardiac-specific promoters, Cardiovasc Res, 35, 560, 10.1016/S0008-6363(97)00154-5 Brand, 1998, Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSV-tk/GCV approach, Gene Ther, 5, 1363, 10.1038/sj.gt.3300728 Wallace, 1991, Specific ablation of thyroid follicle cells in adult transgenic mice, Endocrinology, 129, 3217, 10.1210/endo-129-6-3217 Christophe-Hobertus, 1992, Identification of a transcriptional enhancer upstream from the bovine thyroglobulin gene, Mol Cell Endocrinol, 88, 31, 10.1016/0303-7207(92)90006-R Christophe-Hobertus, 1999, Two binding sites for thyroid transcription factor 1 (TTF-1) determine the activity of the bovine thyroglobulin gene upstream enhancer element, Mol Cell Endocrinol, 149, 79, 10.1016/S0303-7207(98)00250-0 Kintzer, 1991, Heterogeneous effects of growth factors and serum on TSH and forskolin stimulated cAMP levels in continuous cell strains derived from feline toxic nodular goitre, Ann Endocrinol (Paris), 52, 87 Blackwood L. Transcriptional Targeting of Gene Therapy in the Hyperthyroid Cat: Preliminary Investigations. University of Glasgow, PhD, 2000. Roger, 1997, The dog thyroid primary culture system, Eur J Endocrinol, 137, 578, 10.1530/eje.0.1370579